Allergy

Article	Citations
Issue Information	360
Type 2 memory B cells: The repository of allergic memory?	247
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	240
	221
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	214
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	148
In memoriam: Lawrence M. Lichtenstein (1934–2022)	142
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	138
Type I and II Interferons Drive Abacavir Hypersensitivity via Treg Suppression and T‐Cell Enhancement in Immunocompetent HLA	138
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	137
Adherence to Mediterranean Diet During Pregnancy, Breastfeeding, and Development of Food Allergy in the Offspring: Results From the MEDALLION Cohort	125
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	122
Ficolin‐A Protects Against Allergic Asthma via Suppressing ILC2‐Drived Type 2 Inflammation	114
A Systematic Review and Meta‐Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Tas	114
Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses	113
Non‐Releasers in the Basophil Activation Test: A Roadmap for the Correct Reporting and Interpretation	112
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	112
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	108
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	102
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	99
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	97
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	96
Atopic Dermatitis ( AD ) Related Cord Blood DNA Methylation Patterns Are Linked to Maternal	90
Preclinical Development of GR2002 , a Novel Anti‐ TSLP Bispecific Antibody With Potent	86
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	85

Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	83
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	82
Cryopreservation Between Sample Processing and Analysis in Streamlined Basophil Activation Test	81
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3	81
TOP10 ‐ SCAR : A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Rea	79
Transplacental Antimicrobial Antibodies and Childhood Asthma: Maternal Nativity as an Upstream Factor	74
IgG Removal Enhances the Sensitivity of Amoxicillin‐Specific IgE Detection in ImmunoCAP	71
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	70
Interleukin‐22 and Interleukin‐18 as Potential Blood Biomarkers in Dupilumab‐Treated Atopic Dermatitis	70
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	68
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	67
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	67
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	65
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	63
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	61
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	60
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	60
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	59
Issue Information	58
Issue Information	58
Issue Information ‐ TOC	55
Oral abstracts (OAS)	55
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”	54
Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function	54
	53
Issue Information	52
A Streamlined Miniaturized and Multi‐Allergen Basophil Activation Test Platform Amenable to Population‐Based Study	51
Non‐immediate hypersensitivity reactions to iomeprol: Diagnostic value of skin tests and cross‐reactivity with other iodinated contrast media	51
Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice	51
Identification of Shared Regulators of IgE ‐ and MRGPRX2 ‐Dependent Degranulation in Human Mast Ce	51
Novel Bispecific Engagers Targeting the CεmX Domain of mIgE ‐Expressing Cells	50
Evidence of epithelial remodelling but not epithelial–mesenchymal transition by transcriptome profiling in vernal keratoconjunctivitis	50
Tissue‐specific contribution of mucosal‐associated invariant T cells to allergic airway inflammation	49
The Molecular Allergology User's Guide version 2.0 is freely available!	48
Acetylcholine From Solitary Chemosensory Cell, Not Neuron, Regulates Basal Cell Fate Driving Eosinophilic Chronic Rhinosinusitis With Nasal Polyps	48
Severe and refractory anaphylaxis in pediatric intensive care unit	48
Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation	47
Network analysis reveals age‐ and virus‐specific circuits in nasal epithelial cells of extremely premature infants	47
Tissue‐Serum Metabolomics Identifies Lipid Signatures in Eosinophilic Chronic Rhinosinusitis	46
Discrepancies in Beta‐Lactam Antibiotics Cross‐Reactivity: Implications for Clinical Practice	46
Anatomical Distribution and Quantification of IgE Secretion in Mouse Models of House Dust Mite Allergy	46
Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD	45
Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward	45
Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild‐to‐moderate atopic dermatitis: A randomized, double‐blind, vehicle‐controlled trial	45
EAACI guidelines on environmental science in allergic diseases and asthma – Leveraging artificial intelligence and machine learning to develop a causality model in exposomics	44
Forever Chemicals: An Exploratory, Population‐Based Analysis of Per‐ and Polyfluoroalkyl Substances Exposure and Effects on Sinonasal Health	44
Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization	44
Gastrointestinal Barrier Disruption in Post‐COVID Syndrome Fatigue Patients	43
Genistein Reduced Eosinophilic Inflammation and Remodeling by Downregulating PAI ‐1 and TSLP	43
Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study	43

Childhood Asthma and Allergy Are Related to Accelerated Epigenetic Aging	43
Early expansion of allergen‐responsive LAP+ B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy	43
Type 2 IgG Memory B Cells as Precursors of IgE Plasma Cells	43
Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”	42
Allergic Reactivity and Memory Occur Independently of Sequential Switching Through IgG1	42
Childhood infections, asthma and allergy trajectories, and chronic rhinosinusitis in middle age: A prospective cohort study across six decades	41
CT ‐ P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized,	40
Epidemiological Study of Common Allergens Sensitizing Hay Fever Patients in Different Regions of Mainland China	40
Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up	40
Structural Determination of a Human IgE Epitope on Major Birch Allergen Bet v 1	40
SARS‐CoV‐2 infection in severe asthma is associated with worsening of COVID‐19 through respiratory NLRP3 inflammasome activation	39
Issue Information	39
Vulnerability to Pollen‐Related Asthma Hospital Admissions in the UK Biobank: A Case‐Crossover Study	39
Glatiramer acetate induces mast cell degranulation via MRGPRX2, implications for local and systemic adverse reactions	39
Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review	39
IL‐13: An essential cDC2s partner to maintain skin homeostasis	39
Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry	38
Targeting interleukin‐5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms	38
Effect of venom immunotherapy and sting challenge on health‐related quality of life measured by venom‐allergy quality of life questionnaire (VQLQ) in Jack jumper ant allergic patients	38
	38
Harnessing mass spectrometric methods for exquisite allergen product characterization	37
Impact of Residential Greeness Exposure on the Development of Allergic Diseases and Asthma and on Asthma Control—A Systematic Review for the EAACI Gu	37
Issue Information	37
Addressing the Growing Role of Junior Members in EAACI	37
Quantitative analysis of urinary cytokines in food‐allergic and healthy individuals	36
Antibiotics for Acute Wheezing and Asthma Exacerbations: An EAACI Position Paper and Systematic Review	36
A vaccine targeting human IL‐4 and IL‐13 protects against asthma in humanized mice	36
Legends of allergy and immunology: Otto Scheiner	35
Allergen‐Specific B Cell Responses Following Desensitisation and Natural Tolerance to Cow's Milk Allergy	35
Patient‐reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life	35
Narrowband Ultraviolet B Induces Peripheral Regulatory T Cells to Exert Antigen‐Specific Immune Suppression	35
Combining avidin with CD63 improves basophil activation test accuracy in classifying peanut allergy	35
Optimal dose of adrenaline auto‐injector for children and young people at risk of anaphylaxis: A phase IV randomized controlled crossover study	34
Oncostatin‐M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma	34
Comparative Transcriptomic Analysis of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps ( CRSwNP ) Using Nasal Tissue and Brushing Samples	34
Age‐Related Increase in Anaphylaxis Severity Is Associated With Enhanced Sensitivity to Allergic Mediators	34
Incidence of healthcare utilization for allergic and respiratory infectious diseases in children with asthma before and during the COVID‐19 pandemic	34
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry	34
Cost‐effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma	34
Emollients for prevention of atopic dermatitis: 5‐year findings from the BEEP randomized trial	34
Sex hormones and asthma: The role of estrogen in asthma development and severity	33
Salivary Metabolomic Signatures in Pediatric Eosinophilic Esophagitis	33
SEB‐induced IL‐13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis	33
A One‐Strength Dose Escalation Regimen for Birch Pollen SCIT Is Safe and Tolerable in Children, Adolescents, and Adults	33
Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins	33
Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma	33
Anti‐ KIT Barzolvolimab for Chronic Spontaneous Urticaria	32
Intralymphatic Administration of Naked mRNA Induces Allergen‐Specific IgG , Promotes Th1 Responses	32
Impact of a drug allergy education course for non‐specialists: Findings from ADAPT—A randomized crossover trial	32
Molecular Allergen Diagnosis Reveals That Asthma Risk Is Linked to Desert Mugwort Pollen Exposure	32
Efficacy and Safety Profile of Animal Dander Immunotherapy: A Multicentre UK Study	32
Multi‐Omic Analysis of Scylla serrata Reveals the Allergen Landscape of Mud Crabs and Decapoda Species	32
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions	32
Indirect case‐matched comparison of anti‐ IL4Rα versus anti‐ IL5Rα on airway hyperresponsiveness	31
Exiting the Anthropocene: Achieving personal and planetary health in the 21st century	31
Skin Lipid–Microbe Interplay Links Staphylococcus hominis to Barrier Control in Adult Atopic Dermatitis	31
Author Index	30
Efficacy of eHealth monitoring in pediatric asthma	30
Issue Information	30
Issue Information	30
	30
Food Allergy Genetics and Epigenetics: A Review of Genome‐Wide Association Studies	30
Safety of COVID‐19 vaccine challenge in patients with immediate adverse reactions to prior doses: A multi‐centre cohort study	29
IgE glycosylation is essential for the function of omalizumab	29
Interferon‐γ‐inducible protein 10 augments atopic dermatitis via amplifying Th2 immune response	29
Premastication—Review of an Infant Feeding Practice and Its Potential Impact on Allergy and Microbiome Development	29
Mapping the way to strengthening epithelial barriers: Neuronal circuits in mucus regulation	29
Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?	29
Epidemiological variations in global burden of atopic dermatitis: An analysis of trends from 1990 to 2019	29
Legends of Allergy and Immunology: Gianni Marone	29
On a Rainy Day, Placebo Is the Ideal Treatment for Your Hay Fever	29
Is there a direct link between skin barrier dysfunction and asthma?	29
A Case for Anti‐ IgE Vaccination	29
Particulate Matter 2.5 Aggravates Airway Inflammation by Neutrophil‐Mediated Inflammasome Activation	28
An Anti‐IL‐13 Vaccine Reduces Atopic Dermatitis in Humanized Mice and Induces Neutralizing Antibodies in Nonhuman Primates	28
Asthma Remission in Adults: Role of Age at Asthma Onset, Smoking, Obesity, and Allergic Rhinitis	28
Gut microbiota and Lactobacillus species maintain the small intestine stem cell niche and ameliorate the severity of necrotizing enterocolitis	28
Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis	28
Correspondence: Anaphylaxis Induced by Goat's and Sheep's Milk—A Rare Entity in Europe	28
Long‐term follow‐up of neutrophil activation after severe‐to‐critical SARS‐CoV‐2 infection: A longitudinal study	28

Interactive Effects of Ambient Fine Particulate Matter and Ozone on Childhood Allergic Rhinitis: China, Children, Homes, Health Study	28
Pre‐Analytical Stability of Diagnostic Biomarkers in Primary Blood Tubes for Supporting Remote Allergy Care	28
Different mechanisms distinguishing childhood allergic diseases including allergic march	28
Poultry exposure and environmental protection against asthma in rural children	27
Distinct Tryptase Gene Copy Number Variations Correlate With Tryptase Levels in a Population‐Based Cohort	27
A Novel Questionnaire and Algorithm for Work‐Related Asthma Screening and Surveillance: An EAACI Task Force Report	27
Basal Serum Tryptase Outperforms Hereditary Alpha Tryptasemia as a Biomarker of Food Allergy Severity	27
Malassezia ‐Induced Type 2 Immunity in Head Neck Shoulder Type Atopic Dermatitis	27
The Uneven Risks of Childhood Asthma Under Extreme Temperatures and Its Interactions With Environmental Factors	27
Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen‐specific IgE production	27
The stimulation of TH2 cells results in increased IL‐5 and IL‐13 production via the H4 receptor	27
The OX40 / OX40L Axis Promotes Th2 Activity and Impairs Regulatory T Cell Function in Atopic Derma	27
IL‐13, periostin and dipeptidyl‐peptidase‐4 reveal endotype‐phenotype associations in atopic dermatitis	27
Neonatal Bacillus Calmette‐Guérin Vaccination Decreases Eczema Incidence at 5 years: The MIS BAIR Randomised Controlled Trial	27
Flow‐based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper	26
Allergen‐specific B cell responses in oral immunotherapy‐induced desensitization, remission, and natural outgrowth in cow's milk allergy	26
Type 1/17 CD103+CD4+ nasal‐resident memory T cells in non‐eosinophilic chronic rhinosinusitis with nasal polyps	26
Secretion of Peanut Protein With IgE Crosslinking Capacity in Human Milk	26
CLA+ memory T cells in atopic dermatitis	26
Effects of the immunoglobulin/histamine complex in chronic spontaneous urticaria focusing on remission induction	26
The impact of dupilumab treatment on SARS‐CoV‐2 T cell responses in atopic dermatitis patients	26
Fecal microbiota transplantation against moderate‐to‐severe atopic dermatitis: A randomized, double‐blind controlled explorer trial	26
Recombinant Hypoallergenic Cat Allergy Vaccines	26
The Bronchodilator and Anti‐Inflammatory Effect of Long‐Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper	26
Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti‐inflammatory Drug‐Exacerbated Respiratory Disease	26
Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after	26
In this issue: Graphical abstract	25
Issue Information	25
Tissue levels of Alternaria allergen Alt a 1 reflect recurrence of refractory airway diseases	25
Effect‐modifying impact of age on sex‐based differences during oral immunotherapy	25
Effect of indoor air pollution on atopic dermatitis in dogs	25
Infantile colic is associated with development of later constipation and atopic disorders	25
Issue Information	25
	25
The association between allergic rhinitis and the risk of coronavirus disease 2019 (COVID‐19): A national survey in China	24
Healthcare Professional Survey on Complementary Feeding and Allergy Prevention in High‐ Versus Low‐Risk Infants: An EAACI Task Force Report	24
Correction to “Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge”	24
Exhaled Nitric Oxide and Sputum Eosinophils Are Complementary Tools for Diagnosing Occupational Asthma	24
Dietary fiber and fermented food consumption and its link to allergic responses	24
Allergen‐Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years	24
An algorithm for the management of radiocontrast media hypersensitivity, 2024 update	24
Anaphylaxis Induced by Goat's and Sheep's Milk: An Allergen That We Should Keep Under Surveillance	24
Identification of a functional DOCK8 gene polymorphism associated with atopic dermatitis	24
Type 2 Inflammation‐Biased Arachidonic Acid Metabolite Regulates Mucosal Remodeling of Chronic Rhinosinusitis With Nasal Polyps	24
Lipidomic Analysis of Esophageal Epithelia Reveals a Distinctive Sphingolipid Profile in Eosinophilic Esophagitis	24
Reply to correspondence: Emollients in infancy to prevent atopic dermatitis: A systematic review and meta‐analysis	24
Bulk T‐cell receptor sequencing confirms clonality in pediatric eosinophilic esophagitis and identifies a food‐specific repertoire	24
Corrigendum to “Immune Regulation by Intralymphatic Immunotherapy With Modular Allergen Translocation MAT Vaccine”	24
Downregulation of Tight Junction Protein MAGI1 by Interferon‐γ Contributes to Barrier Dysfunction in Chronic Rhinosinusitis With Nasal Polyps	24
Different inflammatory features of asthma according to gut microbiome enterotype	23
AI ‐Assisted Statistical Review: Could It Have Averted Retractions? A Case‐Based Perspective From Immunology	23
Global burden of vaccine‐associated angioedema and their related vaccines, 1967–2023: Findings from the global pharmacovigilance database	23
Sesame eliciting and safe doses in a large sesame allergic population	23
Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis	23
Intestinal STING ‐(Over)activation—A Contributing Factor to Food Allergies?	23
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study	23
Early Epidemiologic and Immune Predictors of Atopic Dermatitis: Reduced Cord Blood Regulatory B10 Cells in the Munich Atopy Prediction Study (	23
Human Milk Microbiome Is Associated With Allergic Diseases in Early Childhood	23
Gut Microbiota‐Derived Secondary Bile Acids Regulate Allergic Diseases	23
Reply to Correspondence: ‘Challenging the Frontier: Bridging Systemic Biomarkers and Small Airway Dynamics in Severe Asthma Management’	23
Multi‐Omics‐Based Biological Mechanisms for Childhood Allergen Sensitization Trajectories: COCOA Study	23
Obituary: Professor Marcus Maurer, Berlin, Germany	23
Making Peanuts Safer: Autoclaving as a Heat and Pressure Strategy to Increase Peanut Tolerability	22
Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL‐13 inhibition	22
Physical exercise, immune response, and susceptibility to infections—current knowledge and growing research areas	22
Dupilumab and Blood Eosinophilia: A Disease‐Specific Phenomenon?	22
Long‐term changes in milk component immunoglobulins reflect milk oral immunotherapy outcomes in Finnish children	22
Helminths' therapeutic potential to treat intestinal barrier dysfunction	22
Systematic review of the association between short‐chain fatty acids and allergic diseases	22
Eosinophilic allergic rhinitis is strongly associated with the CD45RBlo subset of CD161+ Th2 cells that secretes IL‐2, IL‐3, IL	22
Allergenic potency of various foods of mammalian origin in patients with α‐Gal syndrome	22
How type‐2 dendritic cells induce Th2 differentiation: Instruction, repression, or fostering T cell‐T cell communication?	22
Spatial transcriptomics combined with single‐cell RNA‐sequencing unravels the complex inflammatory cell network in atopic dermatitis	22
Legends of allergy and immunology: Alberto Mantovani, a visionary scientist unraveling the complexity of innate immunity in cancer and inflammation	21
Issue Information	21
Migration and allergic diseases: Findings from a population‐based study in adults in Amsterdam, the Netherlands	21
Occupational Mite Allergy and Asthma: An EAACI Task Force Report	21
	21
JM case reports session	21
Patients With Atopic Dermatitis Show Increased Clonal Hematopoiesis and Risk of Hematological Cancer	21
Issue Information ‐ TOC	21
Graphical abstracts and highlights	21
East Meets West in Allergic Airway Disease: Insights From the EAACI Hong Kong Allergy School 2025	21
Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID‐exacerbated respiratory disease	21
Delta or Omicron BA.1/2‐neutralizing antibody levels and T‐cell reactivity after triple‐vaccination or infection	21
	21
Issue information ‐ Cover and Editorial Board	21
Issue Information	21
Induction of immunosuppressive CD39 but not the trafficking C‐C chemokine receptor 4 on Treg during LAR in mite allergic asthma	21
Vitamin D‐FUT2 interaction and risk of lower respiratory tract infections in childhood	21
CMTM4 as a new partner for IL‐17 receptor: Adding a piece in the puzzle of IL17‐driven diseases	21
	20
Association of Atopic Dermatitis or Allergic Rhinitis With Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis	20
Epithelial barrier theory in the context of nutrition and environmental exposure in athletes	20
Tetraspanin CD53 Promotes Inflammation but Restrains Mucus Production in a Mouse Model of Allergic Airway Inflammation	20